Connect with us
The global slowdown in economic growth has so far left Roche and Novartis' businesses untouched. Both drug manufacturers, based in Basel, are currently growing significantly faster...
Parents of children with serious health conditions are facing high costs of healthcare.
Effectively ending their self-imposed halt this year, drugmakers will start the new year with drug price increases.
Teva initially got the chance to launch its drug called fremanezumab before Aimovig, but the opportunity slipped away when there was a delay in its FDA...